The Centers for Disease Control and Prevention (CDC) has provided guidelines on using Siga Technologies’ Tpoxx (tecovirimat) in treating monkeypox.
Boehringer Ingelheim’s monoclonal antibody inhibits interleukin-36 (IL-36) signaling and is the first treatment specifically approved for this indication.
Mallinckrodt plc (MNKPF) said that the U.S. Food and Drug Administration approved Terlivaz (terlipressin) for injection.
London: BA.4.6, a subvariant of the omicron COVID variant which has been quickly gaining traction in the US, is now confirmed to be spreading in the UK.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.